Life360, Inc. (LIF) Spending and interest coverage
- R&D / revenue · 12 months: Value 26.62%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 12.12%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 26.62% | Research and development expense / revenue. Period ending 2026-06-30. $152.42M ÷ $572.56M × 100 ≈ 26.62% |
| Stock-based compensation / revenue · 12 months | 12.12% | Share-based compensation / revenue. Period ending 2026-06-30. $69.42M ÷ $572.56M × 100 ≈ 12.12% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 152.42M USD | Research and Development Expense |
| Revenue | 572.56M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 69.42M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 6.51M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $152.42M | $572.56M | $69.42M | $6.51M | (m) | 26.62% | 12.12% | (m) | (m) |
| 2026-03-31 | $137.28M | $528.98M | $61.83M | $8.56M | (m) | 25.95% | 11.69% | (m) | (m) |
| 2025-12-31 | $128.41M | $489.48M | $55.46M | $18.83M | (m) | 26.23% | 11.33% | (m) | (m) |
| 2025-09-30 | $124.86M | $459.03M | $51.75M | $15.59M | (m) | 27.20% | 11.27% | (m) | (m) |
| 2025-06-30 | $121.46M | $427.40M | $48.34M | $4.95M | (m) | 28.42% | 11.31% | (m) | (m) |
| 2025-03-31 | $116.22M | $396.88M | $43.90M | $592.00K | (m) | 29.28% | 11.06% | (m) | (m) |
| 2024-12-31 | $113.07M | $371.48M | $42.27M | $-7.98M | (m) | 30.44% | 11.38% | (m) | (m) |
| 2024-09-30 | $109.30M | $342.92M | $41.34M | $-18.03M | (m) | 31.87% | 12.06% | (m) | (m) |
| 2024-06-30 | $104.86M | $328.68M | $39.34M | $-19.59M | (m) | 31.90% | 11.97% | (m) | (m) |
| 2024-03-31 | $101.03M | $314.60M | $37.82M | $-21.47M | (m) | 32.11% | 12.02% | (m) | (m) |
| 2023-12-31 | $100.97M | $304.52M | $38.51M | $-29.98M | (m) | 33.16% | 12.65% | (m) | (m) |
| 2023-09-30 | $100.09M | $288.89M | $37.87M | $-38.35M | (m) | 34.65% | 13.11% | (m) | (m) |
| 2023-06-30 | $100.09M | $267.42M | $36.38M | $-52.97M | (m) | 37.43% | 13.60% | (m) | (m) |
| 2023-03-31 | $103.94M | $245.48M | $37.54M | $-82.20M | (m) | 42.34% | 15.29% | (m) | (m) |
| 2022-12-31 | $102.48M | $228.31M | $34.68M | $-94.41M | (m) | 44.89% | 15.19% | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $50.99M | $112.64M | $11.75M | $-32.26M | (m) | 45.27% | 10.43% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $39.64M | $80.66M | $8.09M | $-16.65M | (m) | 49.15% | 10.03% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.